Monitor for any unsolicited takeover interest or activist activity, as the extended rights agreement gives the board more time to respond. The move suggests management wants to maintain control flexibility in a potentially volatile biotech M&A environment.
Price Chart
Executive Summary
Pliant Therapeutics extended the expiration date of its shareholder rights agreement from March 11, 2026 to March 11, 2027. The amendment is designed to prevent coercive takeover attempts by requiring potential acquirers to negotiate with the board, but was not made in response to any specific offer.
Key Financial Metrics
Key Facts
- Pliant Therapeutics extended the expiration of its shareholder rights agreement by one year, from March 11, 2026 to March 11, 2027
- The rights agreement allows the board to delay or prevent unsolicited takeover attempts
- The amendment was not made in response to any specific takeover offer
- The rights may still be redeemed, exchanged, or terminated earlier under existing terms
Financial Impact
No direct financial impact — this is a corporate governance measure
Risk Factors
- Could deter potential acquirers if seen as entrenching management
- May face shareholder opposition if perceived as anti-takeover without clear strategic rationale
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001746473-26-000024 |
| Document: pliant-rightsagreementamen.htm | 0001746473-26-000024 |
| Document: 0001746473-26-000024-index-headers.html | 0001746473-26-000024 |
| Document: 0001746473-26-000024-index.html | 0001746473-26-000024 |
| Document: 0001746473-26-000024.txt | 0001746473-26-000024 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 18, 2026 6w ago | Press Release | $1.15 $1.15 | ▼ −0.43% | ▲ +0.55% | $1.03 (−10.43%) |
May 11, 2026 20w ago | 8-K | $1.18 $1.16 | ▼ −1.69% | ▲ +0.03% | $1.03 (−12.71%) |
May 11, 2026 20w ago | Press Release | $1.18 $1.16 | ▲ +1.69% | ▼ −0.03% | $1.03 (+12.71%) |
Apr 17, 2026 23w ago | 8-K | $1.29 $1.18 | ▼ −8.53% | ▼ −12.73% | $1.03 (−20.16%) |
Apr 7, 2026 25w ago | EFFECT | $1.31 $1.19 | ▼ −9.16% | ▼ −18.94% | $1.03 (−21.37%) |
Mar 11, 2026 29w ago | 8-K | $1.41 $1.28 | ▼ −9.22% | ▼ −11.19% | $1.03 (−26.95%) |
Mar 3, 2026 30w ago | 8-K | $1.29 $1.32 | ▲ +2.33% | ▲ +6.74% | $1.03 (−20.16%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access